Dec. 4, 2002 (Chicago) - A radiopharmaceutical-imaging agent - ioflupane (I123-FP-CIT) - used with single photon emission computed tomography (SPECT) is "98% accurate" for early diagnosis of Parkinson ...
Reston, VA—A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized ...
Please provide your email address to receive an email when new articles are posted on . DocGo and Spect have partnered to provide mobile health clinicians a more cost-effective way to screen patients ...
Chengdu Brilliant Pharmaceutical Co. Ltd. and Chengdu Xinke Pharmaceutical Co. Ltd. have disclosed drug conjugates comprising a bone-targeting moiety covalently bound to a radiolabeled-chelating agent ...
Reston, VA (October 13, 2025)--A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess prostate cancer progression or regression during ...
Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon emission ...
The partnership expands DocGo’s ability to support patients and vulnerable populations NEW YORK--(BUSINESS WIRE)-- DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results